{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:19:59Z","timestamp":1779333599083,"version":"3.51.4"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>The purpose of this study was to evaluate glaucoma and its management in eyes with Boston type 1 keratoprosthesis (Boston-Kpro) and Aurolab keratoprosthesis (Auro-Kpro) in an Indian cohort.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This retrospective comparative case series included 175 eyes of 175 patients who underwent type 1 keratoprosthesis from 2009 until 2017; type 1 Boston-Kpro was performed in 107 eyes (107 patients) and Auro-Kpro in 68 eyes (68 patients). The eyes with &lt;1-month follow-up were excluded, and hence, for the analysis of glaucoma, 62 eyes with Auro-Kpro and 99 eyes with Boston-Kpro were included. Progression was defined as the worsening of optic disc damage\/progression by visual field\/uncontrolled IOP needing additional medications or glaucoma surgery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The post-Kpro mean follow-up was 1.8 \u00b1 1.7 years. After Kpro, overall glaucoma was noted in 61% of eyes (98\/161). Preexisting glaucoma was noted in 28% of eyes (45\/161), postoperative glaucoma was noted in 33% of eyes (53\/161), and 39% of eyes (63\/161) did not have glaucoma. Among those with preexisting glaucoma, 49% of eyes (22\/45) progressed after Kpro implantation. The proportion of eyes with glaucoma in Auro-Kpro (56.5% of eyes) and Boston-Kpro (63.6% of eyes) was similar (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.46). The Kaplan\u2013Meier curve for cumulative survival (Kpro-retention rate) was similar in eyes with and without glaucoma (83% vs. 76% at 1 year, 72% vs. 70% at 2 years; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.65). A higher number of prior intraocular surgeries (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.04) was significantly associated with risk for postoperative glaucoma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Glaucoma was seen in more than half of the eyes with type 1 keratoprosthesis. The presence of glaucoma did not seem to affect the retention of keratoprosthesis. A high rate of postoperative glaucoma and the progression of preexisting glaucoma need close monitoring and appropriate management.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ico.0000000000002986","type":"journal-article","created":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T17:22:00Z","timestamp":1643217720000},"page":"552-561","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Glaucoma Evaluation and Management in Eyes With Boston Type 1 and Aurolab Keratoprostheses in an Indian Cohort"],"prefix":"10.1097","volume":"41","author":[{"given":"Sirisha","family":"Senthil","sequence":"first","affiliation":[{"name":"VST Glaucoma Center, L V Prasad Eye Institute, Hyderabad, India;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashik","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Ophthalmic Biophysics, L V Prasad Eye Institute, Hyderabad, India;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swapna S.","family":"Shanbhag","sequence":"additional","affiliation":[{"name":"The Cornea Institute, L V Prasad Eye Institute, Hyderabad, India; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shravya Sri","family":"Durgam","sequence":"additional","affiliation":[{"name":"Ophthalmic Biophysics, L V Prasad Eye Institute, Hyderabad, India;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhupesh","family":"Bagga","sequence":"additional","affiliation":[{"name":"The Cornea Institute, L V Prasad Eye Institute, Hyderabad, India; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virender S.","family":"Sangwan","sequence":"additional","affiliation":[{"name":"Shroffs Charity Eye Hospital, New Delhi, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayan","family":"Basu","sequence":"additional","affiliation":[{"name":"The Cornea Institute, L V Prasad Eye Institute, Hyderabad, India; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,1,25]]},"reference":[{"key":"R1-20250728","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ophtha.2008.12.058","article-title":"The Boston type I keratoprosthesis: improving outcomes and expanding indications","volume":"116","author":"Aldave","year":"2009","journal-title":"Ophthalmology"},{"key":"R2-20250728","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.ophtha.2006.05.015","article-title":"Results from the multicenter Boston type 1 keratoprosthesis study","volume":"113","author":"Zerbe","year":"2006","journal-title":"Ophthalmology"},{"key":"R3-20250728","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/IIO.0b013e318036bd8b","article-title":"Advances in Boston keratoprosthesis: enhancing retention and prevention of infection and inflammation","volume":"47","author":"Khan","year":"2007","journal-title":"Int Ophthalmol Clin."},{"key":"R4-20250728","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/IIO.0b013e318169511f","article-title":"The role of soft contact lenses as an adjunct to the Boston keratoprosthesis","volume":"48","author":"Harissi-Dagher","year":"2008","journal-title":"Int Ophthalmol Clin."},{"key":"R5-20250728","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/ICO.0b013e31820f7a32","article-title":"Glaucoma associated with Boston type 1 keratoprosthesis","volume":"31","author":"Kamyar","year":"2012","journal-title":"Cornea"},{"key":"R6-20250728","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/ICU.0b013e328343723d","article-title":"Evaluation and management of glaucoma after keratoprosthesis","volume":"22","author":"Banitt","year":"2011","journal-title":"Curr Opin Ophthalmol."},{"key":"R7-20250728","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0161-6420(98)94034-9","article-title":"Glaucoma associated with keratoprosthesis","volume":"105","author":"Netland","year":"1998","journal-title":"Ophthalmology"},{"key":"R8-20250728","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/ICO.0b013e3181a186dc","article-title":"Boston keratoprosthesis outcomes and complications","volume":"28","author":"Chew","year":"2009","journal-title":"Cornea"},{"key":"R9-20250728","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3928\/1542-8877-19980901-10","article-title":"Digital palpation of intraocular pressure","volume":"29","author":"Birnbach","year":"1998","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"R10-20250728","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.ajo.2013.05.045","article-title":"Correlation between corneal and scleral pneumatonometry: an alternative method for intraocular pressure measurement","volume":"156","author":"Kapamajian","year":"2013","journal-title":"Am J Ophthalmol."},{"key":"R11-20250728","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/ICO.0000000000002033","article-title":"Schiotz scleral intraocular pressure readings predict goldmann applanation readings better than rebound tonometry","volume":"38","author":"Senthil","year":"2019","journal-title":"Cornea"},{"key":"R12-20250728","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/IJG.0b013e3181815485","article-title":"Glaucoma and keratoprosthesis surgery: role of adjunctive cyclophotocoagulation","volume":"18","author":"Rivier","year":"2009","journal-title":"J Glaucoma"},{"key":"R13-20250728","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajo.2011.07.022","article-title":"Prevalence, progression, and impact of glaucoma on vision after Boston type 1 keratoprosthesis surgery","volume":"153","author":"Talajic","year":"2012","journal-title":"Am J Ophthalmol."},{"key":"R14-20250728","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1097\/ICO.0b013e31821eead6","article-title":"Glaucoma in eyes with severe chemical burn, before and after keratoprosthesis","volume":"30","author":"Cade","year":"2011","journal-title":"Cornea"},{"key":"R15-20250728","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/IIO.0b013e3181e20cca","article-title":"The boston keratoprosthesis","volume":"50","author":"Klufas","year":"2010","journal-title":"Int Ophthalmol Clin."},{"key":"R16-20250728","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ajo.2019.03.016","article-title":"The Aurolab keratoprosthesis (KPro) versus the Boston type I Kpro: 5-year clinical outcomes in 134 cases of bilateral corneal blindness","volume":"205","author":"Basu","year":"2019","journal-title":"Am J Ophthalmol."},{"key":"R17-20250728","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ajo.2016.12.018","article-title":"Role of diagnostic endoscopy in posterior segment evaluation for definitive prognostication in eyes with corneal opacification","volume":"176","author":"Pappuru","year":"2017","journal-title":"Am J Ophthalmol."},{"key":"R18-20250728","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/bjophthalmol-2020-316369","article-title":"Outcomes of the Boston type 1 and the Aurolab keratoprosthesis in eyes with limbal stem cell deficiency","volume":"105","author":"Shanbhag","year":"2020","journal-title":"Br J Ophthalmol."},{"key":"R19-20250728","article-title":"Estimation of Goldmann applanation tonometer intraocular pressure (IOP) from scleral Schiotz IOP values in eyes with type-1 keratoprosthesis","author":"Senthil","year":"2020","journal-title":"Br J Ophthalmol."},{"key":"R20-20250728","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/ICO.0000000000002098","article-title":"Systematic review and meta-analysis of the medium- and long-term outcomes of the boston type 1 keratoprosthesis","volume":"38","author":"Priddy","year":"2019","journal-title":"Cornea"},{"key":"R21-20250728","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2147\/OPTH.S219270","article-title":"Boston type 1 keratoprosthesis: updated perspectives","volume":"14","author":"Nonpassopon","year":"2020","journal-title":"Clin Ophthalmol."},{"key":"R22-20250728","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.ophtha.2015.03.025","article-title":"Boston keratoprosthesis: outcomes and complications: a report by the American academy of ophthalmology","volume":"122","author":"Lee","year":"2015","journal-title":"Ophthalmology"},{"key":"R23-20250728","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/ICO.0000000000001544","article-title":"Assessment of glaucomatous damage after boston keratoprosthesis implantation based on digital planimetric quantification of visual fields and optic nerve head imaging","volume":"37","author":"Ali","year":"2018","journal-title":"Cornea"},{"key":"R24-20250728","first-page":"1601","article-title":"Long-term visual outcomes of the Boston type I keratoprosthesis in Canada","volume":"104","author":"Szigiato","year":"2020","journal-title":"Br J Ophthalmol."},{"key":"R25-20250728","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1097\/ICO.0b013e31823f7765","article-title":"Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure","volume":"31","author":"Kang","year":"2012","journal-title":"Cornea"},{"key":"R26-20250728","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/ICO.0000000000000886","article-title":"Boston type 1 keratoprosthesis: visual outcomes, device retention, and complications","volume":"35","author":"Goins","year":"2016","journal-title":"Cornea"},{"key":"R27-20250728","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/ICO.0000000000000067","article-title":"Glaucoma progression and role of glaucoma surgery in patients with Boston keratoprosthesis","volume":"33","author":"Crnej","year":"2014","journal-title":"Cornea"},{"key":"R28-20250728","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.ophtha.2012.02.015","article-title":"International results with the Boston type I keratoprosthesis","volume":"119","author":"Aldave","year":"2012","journal-title":"Ophthalmology"},{"key":"R29-20250728","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1097\/ICO.0000000000000265","article-title":"Medium-term outcomes of boston type 1 keratoprosthesis implantation in Bangkok, Thailand","volume":"33","author":"Lekhanont","year":"2014","journal-title":"Cornea"},{"key":"R30-20250728","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/ICO.0000000000000357","article-title":"Primary implantation of type I Boston keratoprosthesis in nonautoimmune corneal diseases","volume":"34","author":"Chang","year":"2015","journal-title":"Cornea"},{"key":"R31-20250728","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/eye.2011.325","article-title":"Boston type 1 keratoprosthesis: the New York Eye and Ear experience","volume":"26","author":"Patel","year":"2012","journal-title":"Eye"},{"key":"R32-20250728","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/ICO.0000000000000933","article-title":"Long-term outcomes of the boston type I keratoprosthesis in the management of corneal limbal stem cell deficiency","volume":"35","author":"Aravena","year":"2016","journal-title":"Cornea"},{"key":"R33-20250728","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s40135-016-0102-3","article-title":"Innovative approaches to glaucoma management of Boston keratoprosthesis type 1","volume":"4","author":"Vajaranant","year":"2016","journal-title":"Curr Ophthalmol Rep."},{"key":"R34-20250728","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ophtha.2016.08.003","article-title":"Safety of concurrent boston type I keratoprosthesis and glaucoma drainage device implantation","volume":"124","author":"Lenis","year":"2017","journal-title":"Ophthalmology"},{"key":"R35-20250728","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ajo.2011.01.034","article-title":"Long-term complications associated with glaucoma drainage devices and Boston keratoprosthesis","volume":"152","author":"Li","year":"2011","journal-title":"Am J Ophthalmol."},{"key":"R36-20250728","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1097\/IJG.0b013e31829e55f8","article-title":"Outcomes of pars plana glaucoma drainage implant in Boston type 1 keratoprosthesis surgery","volume":"23","author":"Huh","year":"2014","journal-title":"J Glaucoma"},{"key":"R37-20250728","doi-asserted-by":"crossref","first-page":"e0182190","DOI":"10.1371\/journal.pone.0182190","article-title":"Vision retention in early versus delayed glaucoma surgical intervention in patients with Boston Keratoprosthesis type 1","volume":"12","author":"Lin","year":"2017","journal-title":"PLoS One"},{"key":"R38-20250728","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/bjophthalmol-2012-302770","article-title":"Complications associated with Boston keratoprosthesis type 1 and glaucoma drainage devices","volume":"97","author":"Robert","year":"2013","journal-title":"Br J Ophthalmol."},{"key":"R39-20250728","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ajo.2012.03.001","article-title":"Chronic hypotony associated with the Boston type 1 keratoprosthesis","volume":"154","author":"Dokey","year":"2012","journal-title":"Am J Ophthalmol."},{"key":"R40-20250728","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/bjo.2010.189571","article-title":"Delayed suprachoroidal haemorrhage following Boston Keratoprosthesis in two aniridic patients","volume":"95","author":"Qian","year":"2011","journal-title":"Br J Ophthalmol."},{"key":"R41-20250728","first-page":"3577","article-title":"Glaucoma outcomes following boston keratoprosthesis type 1 surgery","volume":"61","author":"Geoffrion","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R42-20250728","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/ICO.0b013e3181b6eb9e","article-title":"Incidence of and risk factors for increased intraocular pressure after penetrating keratoplasty","volume":"29","author":"Karadag","year":"2010","journal-title":"Cornea"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0000000000002986","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T22:07:56Z","timestamp":1753740476000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0000000000002986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,25]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0000000000002986","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,25]]},"assertion":[{"value":"2021-01-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}